GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy

Achievement of long-term survival of patients with lung cancer treated with conventional chemotherapy is still difficult for treatment of metastatic and advanced tumors. Despite recent progress in investigational therapies, survival rates are still disappointingly low and novel adjuvant and systemic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chang, Seung-Hee, Hong, Seong-Ho, Jiang, Hu-Lin, Minai-Tehrani, Arash, Yu, Kyeong-Nam, Lee, Jae-Ho, Kim, Ji-Eun, Shin, Ji-Young, Kang, Bitna, Park, Sungjin, Han, Kiwon, Chae, Chanhee, Cho, Myung-Haing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2012
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3498792/
https://ncbi.nlm.nih.gov/pubmed/22735382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.125
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller